Clinical Trials Logo
  1. Home
  2. Williams Syndrome
  3. NCT02212314

Response Inhibition Training for Children With Williams Syndrome — WSRIT  

Williams Syndrome Clinical Trial

Official title:
Developing Treatments to Improve Psychosocial Functioning in Children With Williams Syndrome Part 1: Response Inhibition Training for Children With Williams Syndrome

Clinical Trial Summary

The investigators will conduct a pilot study investigating the effectiveness of a computerized response inhibition training program at reducing the response inhibition difficulties often seen in children with Williams syndrome ages 10-17. The investigators hypothesize that after completing the training program, children with Williams syndrome will show improvement on computerized measures of response inhibition and on parent measures of impulsivity.

Clinical Trial Description

Behavioral characteristics of individuals with Williams syndrome include eagerness to approach and interact with others (including strangers), repeated questions especially about upcoming events, and difficulties with attention, impulsivity, and inhibition. There is very little systematic research about the kinds of interventions that are most useful for children with Williams syndrome to support optimal psychosocial functioning, and of the effectiveness of such interventions. We will conduct a pilot study of a potential intervention to address the response inhibition difficulties associated with Williams syndrome. The investigators will examine the utility of an online, web-based computerized cognitive retraining program aimed at addressing impulsivity and inhibition difficulties in 20 children, ages 10-17, with WS. The engaging training program has shown some utility in other populations, including children with tic disorders and trichotillomania. The investigators will examine the acceptability and feasibility of the treatment approach, as well as its impact on performance on experimental measures of impulsivity and on everyday psychosocial functioning as rated by parents; this study will consist of a small-scale pilot Randomized Clinical Trial with wait list. Through this novel work, we hope to develop and tune this approach for optimal outcomes and to demonstrate the promise of this intervention to address common challenges of people with Williams syndrome in the area of inhibition. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02212314
Study type Interventional
Source University of Wisconsin, Milwaukee
Contact
Status Completed
Phase N/A
Start date May 2014
Completion date May 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT00004351 - Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes N/A
Completed NCT03758651 - Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study
Enrolling by invitation NCT03836300 - Parent-Infant Inter(X)Action Intervention (PIXI) N/A
Recruiting NCT00768820 - The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome Phase 4
Recruiting NCT04610424 - Cooperative Parent Mediated Therapy in Children With Fragile X Syndrome and Williams Syndrome N/A
Recruiting NCT02706639 - Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank
Completed NCT02692846 - WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)
Recruiting NCT06315699 - Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome Phase 3
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Recruiting NCT01132885 - Defining the Brain Phenotype of Children With Williams Syndrome
Recruiting NCT06087757 - Clemastine Treatment in Individuals With Williams Syndrome Phase 3
Enrolling by invitation NCT05430763 - Motor Deficits and Signal Conduction in Individuals With Williams Syndrome
Completed NCT01864304 - Fat Distribution and Glucose Metabolism in Williams Syndrome N/A
Recruiting NCT02840448 - Impact of Elastin Mediated Vascular Stiffness on End Organs
Recruiting NCT03827525 - Cognitive and Behavioral Therapy of Anxiety in Williams Syndrome
Completed NCT04807517 - Buspirone Treatment of Anxiety in Williams Syndrome Phase 4
Completed NCT00013962 - Vitamin D Metabolism and the Williams Syndrome N/A